Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Tyra Biosciences Inc.

    NASDAQ: TYRA · Real-Time Price · USD
    9.16
    -0.67 (-6.82%)
    At close: Jun 27, 2025, 3:59 PM
    9.10
    -0.66%
    After-hours: Jun 27, 2025, 05:13 PM EDT

    Tyra Biosciences Statistics

    Share Statistics

    Tyra Biosciences has 53.18M shares outstanding. The number of shares has increased by -3.29% in one year.

    Shares Outstanding

    n/a
    		 53.18M

    Shares Change (YoY)

    n/a
    		 -3.29%

    Shares Change (QoQ)

    n/a
    		 -4.01%

    Owned by Institutions (%)

    n/a
    		 82.57%

    Shares Floating

    n/a
    		 32.06M

    Failed to Deliver (FTD) Shares

    n/a
    		 5,792

    FTD / Avg. Volume

    n/a
    		 1.71%

    Short Selling Information

    The latest short interest is 4.98M, so 9.36% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 4.98M

    Short % of Shares Out

    n/a
    		 9.36%

    Short % of Float

    n/a
    		 13.73%

    Short Ratio (days to cover)

    n/a
    		 19.62

    Valuation Ratios

    The PE ratio is -9.2 and the forward PE ratio is -4.05. Tyra Biosciences's PEG ratio is 1.35.

    PE Ratio

    n/a
    		 -9.2

    Forward PE

    n/a
    		 -4.05

    PS Ratio

    n/a
    		 0

    Forward PS

    n/a
    		 4.4

    PB Ratio

    n/a
    		 2.32

    P/FCF Ratio

    n/a
    		 -11.29

    PEG Ratio

    n/a
    		 1.35
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Tyra Biosciences.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 23.81, with a Debt / Equity ratio of 0.02.

    Current Ratio

    n/a
    		 23.81

    Quick Ratio

    n/a
    		 23.81

    Debt / Equity

    n/a
    		 0.02

    Debt / EBITDA

    n/a
    		 -0.07

    Debt / FCF

    n/a
    		 -0.09

    Interest Coverage

    n/a
    		 0

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 n/a

    Profits Per Employee

    n/a
    		 $-1,441,350

    Employee Count

    n/a
    		 60

    Asset Turnover

    n/a
    		 0

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by -36.57% in the last 52 weeks. The beta is 1.07, so Tyra Biosciences's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.07

    52-Week Price Change

    n/a
    		 -36.57%

    50-Day Moving Average

    n/a
    		 9.81

    200-Day Moving Average

    n/a
    		 14.34

    Relative Strength Index (RSI)

    n/a
    		 50.07

    Average Volume (20 Days)

    n/a
    		 339,143

    Income Statement

    Revenue

    n/a
    		 n/a

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 -104.18M

    Net Income

    n/a
    		 -86.48M

    EBITDA

    n/a
    		 -85.96M

    EBIT

    n/a
    		 -86.48M

    Earnings Per Share (EPS)

    n/a
    		 -1.51
    Full Income Statement

    Balance Sheet

    The company has 91.97M in cash and 6.22M in debt, giving a net cash position of 85.74M.

    Cash & Cash Equivalents

    n/a
    		 91.97M

    Total Debt

    n/a
    		 6.22M

    Net Cash

    n/a
    		 85.74M

    Retained Earnings

    n/a
    		 -251.31M

    Total Assets

    n/a
    		 343.48M

    Working Capital

    n/a
    		 310.32M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -69.77M and capital expenditures -664K, giving a free cash flow of -70.44M.

    Operating Cash Flow

    n/a
    		 -69.77M

    Capital Expenditures

    n/a
    		 -664K

    Free Cash Flow

    n/a
    		 -70.44M

    FCF Per Share

    n/a
    		 -1.23
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 n/a

    Pretax Margin

    n/a
    		 n/a

    Profit Margin

    n/a
    		 n/a

    EBITDA Margin

    n/a
    		 n/a

    EBIT Margin

    n/a
    		 n/a

    FCF Margin

    n/a
    		 n/a

    Dividends & Yields

    TYRA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for TYRA is $30.5, which is 211.2% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $30.5

    Price Target Difference

    n/a
    		 211.2%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 6
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 13.63

    Piotroski F-Score

    n/a
    		 1

    Add to Watchlist